National Cancer Centre, Singapore
137
31
38
46
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.5%
13 terminated/withdrawn out of 137 trials
78.0%
-8.5% vs industry average
7%
9 trials in Phase 3/4
0%
0 of 46 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (137)
International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
Role: collaborator
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
Role: lead
Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)
Role: lead
Telegenetics or In-Person Genetic Counselling
Role: lead
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
Role: lead
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
Role: lead
Acceptability and Feasibility of PSC Model of Serious Illness Communication
Role: lead
Histotripsy for Ablation of Liver Tumours in Asia
Role: lead
Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
Role: collaborator
Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore
Role: lead
Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
Role: lead
Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)
Role: collaborator
Window of Opportunity Study in Colorectal Cancer
Role: lead
Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
Role: lead
Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
Role: lead
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Role: lead
Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers
Role: lead
The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
Role: lead
Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
Role: lead
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Role: lead